{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPvg_KMJDA","lastupdate":"2023-10-12T00:00:00.000Z","update_date":"2023-10-12T00:00:00.000Z","lastModified":"Sep 14, 2024","active":1,"confidence_score":101,"confidence_score_reason":"markets","urlname":"aivf1","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$vewjWY0QJJU5D1rnVIcDyP9g25kakM2sxh7jc0jK0d1Kgx11XchPLa.jpeg","name":"AIVF","oneliner":"AI-assisted Technology for IVF Treatments","registrar":"515768372","website":"https://aivf.co","careerspage":"http://www.aivf.co/careers","founded_month":1,"founded_year":2018,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/AiVFtech","youtube":"https://www.youtube.com/channel/UCq_rBpqsKz5PIzs8ei6otfw","facebook":"https://www.facebook.com/profile.php?id=100070652641691","linkedin":"https://www.linkedin.com/company/27952236","instagram":"https://www.instagram.com/aivf.aivf"},"social":["https://www.facebook.com/profile.php?id=100070652641691","https://www.instagram.com/aivf.aivf","https://www.linkedin.com/company/27952236","https://www.youtube.com/channel/UCq_rBpqsKz5PIzs8ei6otfw","https://twitter.com/AiVFtech"],"flattenedsociallinks":"https://www.facebook.com/profile.php?id=100070652641691|https://www.instagram.com/aivf.aivf|https://www.linkedin.com/company/27952236|https://www.youtube.com/channel/UCq_rBpqsKz5PIzs8ei6otfw|https://twitter.com/AiVFtech","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":35,"patent":1,"raised":25000000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["A-I-V-F","A.I.V.F"],"about":"AIVF is leading the next generation of IVF. The company is on a mission to help patients, clinics and labs achieve the best IVF outcomes by developing advanced AI solutions. Its AI solutions pioneer the convergence of digitization and automation in the IVF clinic to help patients on a smoother, quicker and more accessible path to parenthood.\n\nEMA by AIVF is an AI-powered platform tailored exactly to the needs of the IVF clinic. The digital workspace connects the entire care team to fully automated AI-based embryo evaluation, streamlined communications and powerful analytics tools.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"9de09187-8517-474b-80cb-26977f803011","city":"Tel Aviv-Yafo","type":null,"address":"HaBarzel Street 11, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"3WKlrSXtNLwjlq1vnW3LlOAZBGajgoxFJgDdoYEphCklsDVhTPGBLD","date":"Oct 29, 2023","link":"https://www.maariv.co.il/business/tech/Article-1048630?_atscid=7_134353_204082920_2491395_0_Txtetaxjxdshwhus8sp","source":"www.maariv.co.il","visible":1,"analysis":{"tags":"Healthcare, Artificial Intelligence","company":"AIVF","layoffs":"N/A","summary":"Israeli start-up AIVF, which develops artificial intelligence-based solutions for fertility, is setting up a multi-disciplinary forum to support women undergoing IVF treatment during uncertain times. The forum will meet once a week to discuss relevant issues and will include experts in the fields of fertility, nutrition, embryology, and mental health. The initiative is aimed at creating a supportive environment and providing professional answers to those grappling with fertility and pregnancy issues.","partners":"N/A","customers":"Women undergoing IVF treatment","investors":"N/A","confidence":8,"key_topics":"Artificial Intelligence, Fertility Treatment, Community Forum, Healthcare","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QK8OoJnHba45Dn0pLycYH6oLMFf5A3fiKXci6xp54HpAq4pAqxJUyc","news_summary":"הסטארט-אפ AIVF מגבש פורום להתמודדות עם טיפולי פוריות בעת מלחמה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"pGNCOKUo2G2QKYloDUETc9RBH3nanfUS5YDpfAkAiwKD0bPPKw6nzq","date":"Sep 27, 2023","link":"https://www.prnewswire.com/news-releases/aivf-expands-launching-the-first-ai-powered-ivf-solution-at-the-perfetto-clinic-in-goiania-brazil-301940276.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Expansion, AI Technology","company":"AIVF","layoffs":"Not mentioned","summary":"AIVF, a reproductive technology company, has launched the first AI-powered IVF operating system in Brazil at Perfetto, a multidisciplinary fertility clinic. The expansion aims to address the growing demand for assisted reproductive technologies in Brazil. AIVFs EMA™ is designed to improve clinical decision-making, streamline operations, and strengthen clinic-patient communications. The systems deep learning AI models were developed on large and diverse databases from leading institutions across the US, Europe, and Asia. The launch is part of AIVFs efforts to meet the increasing demand for advanced fertility solutions.","partners":"Not mentioned","customers":"Perfetto","investors":"Not mentioned","confidence":9,"key_topics":["IVF Treatment","AI Technology","Expansion","Brazil Market","Efficiency Improvement"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"w0Du7aBFhlZD4Pb7UEpqwggETehff0FYdhjCjjw3rIVGW1dky4xpNa","news_summary":"AIVF Expands Launching the First AI-Powered IVF Solution at the Perfetto Clinic in Goiânia, Brazil","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"lFg47gYb28TDZUS7VciNyPuo8iY8p3icxdQZH4f5fDsYwlijVMQxS0","date":"Jun 21, 2023","link":"https://www.prnewswire.com/news-releases/aivf-awarded-as-2023-technology-pioneer-by-world-economic-forum-301855984.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Technology Pioneers","company":"AIVF","layoffs":null,"summary":"AIVF, a Tel Aviv-based developer of AI-based solutions for IVF clinics, has been selected as one of the World Economic Forums Technology Pioneers. AIVF uses artificial intelligence to optimize the IVF journey. As a Technology Pioneer, AIVF will engage with the World Economic Forum and work with global leaders to address industry and societal issues. The Technology Pioneer cohort includes startups from 31 economies, with a third led by a woman chief executive. AIVF is developing generative AI models to maximize success rates and streamline the clinical process in the IVF lab.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["AI-powered solutions","IVF accessibility","World Economic Forum","Technology Pioneers","AI in healthcare"],"date_of_event":"2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gI7PQ57pQmdJ2yeepWn54soL8z2OjS1n3quRN1Xw2t7izVwACJ17Uf","news_summary":"AIVF Awarded as 2023 Technology Pioneer by World Economic Forum","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bANuqmqrGpCCgnfuKzywfHYl13e8qMIo7BWCG7pdsMbScS8PGH40PT","date":"May 24, 2023","link":"https://femtechinsider.com/aivf-genea-biomedx-partnership/","source":"femtechinsider.com","visible":1,"analysis":{"tags":"partnership, IVF clinics","company":"AIVF","layoffs":null,"summary":"AIVF has formed a partnership with Genea Biomedx to enhance the efficiency and success rates of IVF clinics worldwide. The partnership integrates AIVFs AI platform with Genea Biomedxs time-lapse incubator, offering personalized and optimized IVF care. The solution reduces costs for patients and improves clinic revenues by increasing efficiency and patient access. AIVFs suite of solutions connects patients, clinics, and labs, providing transparent insights and data for IVF treatments. The partnership signifies a new generation of data-driven IVF clinics. The integrated solution has been tested and validated, showing improved success rates and birthrates.","partners":["Genea Biomedx"],"customers":null,"investors":null,"confidence":9,"key_topics":["AIVF","Genea Biomedx","IVF clinics","AI platform","time-lapse incubator"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KAIFNnBM5z3mLrcpnahvrsYKsOmN4c5OZN5WWLyDzThxIhOxxNBJoI","news_summary":"Fertility Companies AIVF and Genea Biomedx Partner to Improve IVF Success Rates and Care","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dOXTbiDrMtuYbmOqg6oUHqrWzdTPg0RiwZVyEAz4m6JRtYEk86J2xs","date":"May 19, 2023","link":"https://www.healthcarefinancenews.com/news/israeli-ivf-startup-looks-democratize-fertility-coverage-united-states","source":"www.healthcarefinancenews.com","visible":1,"analysis":{"tags":"healthcare, AI","company":"AIVF","layoffs":null,"summary":"AIVF, a company specializing in in-vitro fertilization (IVF), is using AI to improve success rates and make IVF more accessible. In the United States, the cost of IVF treatment is high and insurance coverage is limited, creating a gap in coverage for many women. AIVF, founded by Daniella Gilboa, aims to address this issue by expanding in the US and working with health plans to lower the cost of IVF treatment. The company recently raised $25 million in Series A funding and acquired ART Compass, a company that develops lab-management software for IVF. AIVFs AI platform helps assess embryo quality and improve success rates. In Israel, where IVF is more accessible, 5% of babies are born through IVF compared to 2% in the US.","partners":["ART Compass"],"customers":null,"investors":null,"confidence":9,"key_topics":["IVF","health equity","AI","fertility treatment","embryo quality"],"date_of_event":"October 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$25 million","structured_issues":["Expand","Investment","Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Expand  #Investment  #Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gitvyUYIjxeYQEBAkEjgikaHOwvHQPaE8SvUVGuDUBkNNRknAG6Zj6","news_summary":"Israeli IVF startup looks to democratize fertility coverage in the United States","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"td5NfPYD6W69wCgOpUQn0fXcesOlsTJCdimEY13MEuGaBNhkB0DNAL","date":"Oct 24, 2022","link":"https://www.prnewswire.com/il/news-releases/aivf-acquires-art-compass-to-drive-the-digital-transformation-of-fertility-care-301657285.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"AIVF","layoffs":null,"summary":"Reproductive technology company AIVF has announced the acquisition of ART Compass, a leading application for the management of the IVF laboratory. This acquisition expands AIVFs offering and creates traction in the US with an extensive user base. The integration of ART Compass into AIVFs platform for fertility clinics is planned for Q1 2023.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["AIVF","ART Compass","acquisition","fertility care","digital transformation"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6EXkVmgUtNAZxid7ENb4p5rpVNuK2mBUjztKEqqCpzSawEeuT5C7RP","news_summary":"AIVF ACQUIRES ART COMPASS TO DRIVE THE DIGITAL TRANSFORMATION OF FERTILITY CARE","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7573a1fb-3703-46f6-bb1e-c700f1aa8c55","date":"Jun 20, 2022","link":"https://www.businesswire.com/news/home/20220622005156/en/AiVF-Raises-25-Million-in-Series-A-Round-Led-by-Insight-Partners-to-Help-More-People-Become-Parents","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"Snznf4Oc5dVd5C5soswBF0b1s1GH3RlzlYOG7ZCw4lqtG3uDsjw7KK","news_summary":"AiVF Raises $25 Million in Series A Round Led by Insight Partners to Help More People Become Parents","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"cf314a05-1743-4af4-a7e6-e3abb62ecf70","date":"Apr 28, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3906485,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"IVF, AI technology","company":"AiVF","layoffs":null,"summary":"AiVF has received the European stamp of approval for its AI-based digital embryology management platform, EMA, and is seeking approval in the U.S. The platform aims to improve the success rates of IVF treatment by combining AI, computer vision, and big data. The company has the largest embryo database in the world and offers objective and automatic tools. AiVFs solution could lower the cost of IVF treatments and improve the chances of successful pregnancies. The company has also welcomed Dan Ariely as its Chief Behavioral Officer to develop social and behavioral strategies for IVF treatment. AiVF was founded in 2018 and is backed by private equity and scientific grants.","partners":null,"customers":null,"investors":"private equity and scientific grants from European and Israeli sources","confidence":9,"key_topics":["AI technology","IVF treatment","CE Mark","Embryology management platform","Genetic evaluation tool"],"date_of_event":"2021-04-28","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uFV6G3XldynfWugwh5881BfeR6QhtpXMst1xw0Rd6cDF1lit3oBppE","news_summary":"AiVF receives European CE Mark for its AI-based IVF treatments","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e4b45849-5032-4689-bfde-ca5b7ba77c91","date":"Feb 7, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3892195,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"biotech, AI","company":"AIVF","layoffs":null,"summary":"Israeli biotech startup AIVF has developed a noninvasive method for testing embryos in vitro to detect genetic abnormalities using artificial intelligence. The technology uses a scanning device and an algorithm to analyze a larger data sample, providing a clearer picture of whether an embryo is normal or not. The traditional method of preimplantation genetic testing (PGT) using a biopsy is often unreliable and can harm the embryo. AIVFs technology aims to address these issues and improve the accuracy of embryo testing. The company is currently conducting clinical trials in Spain and plans to expand to hospitals and clinics in the US and Europe. The technology has the potential to change the approach to in vitro fertilization (IVF) and improve outcomes.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["AI","genetic abnormalities","embryo testing","noninvasive method","data analysis"],"date_of_event":"07.02.21","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"UhyGduJyFmY9COtc1CrpM3AnBH5R4zWg47yCrnjecIets8QJhT3W5t","news_summary":"Israeli researchers devise non-invasive genetic testing screens to ensure healthy fetuses","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e0d0a1fe-45e9-4d03-bb59-45052b8b067e","date":"Dec 30, 2020","link":"https://spectrum.ieee.org/tech-talk/biomedical/diagnostics/how-ai-is-transforming-assisted-reproductive-technology","source":"spectrum.ieee.org","visible":1,"analysis":{"tags":"Artificial Intelligence, Healthcare","company":"AiVF","layoffs":"Not mentioned","summary":"Israeli machine learning startup AiVF is using artificial intelligence (AI) to improve the success rate of in vitro fertilization (IVF). The companys AI system could potentially triple the success rate of IVF compared to traditional methods. AiVF uses machine learning and computer vision technology to allow embryologists to discover which embryos have the most potential for success during intrauterine implantation. The company is currently working with eight facilities in clinical trials around the world, including in Israel, Europe, and the United States, and plans to launch commercially in 2021.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":"Artificial Intelligence, In Vitro Fertilization, Machine Learning, Computer Vision, Healthcare","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":"Customers, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"LuuMKzRlfuAKmiEe0k5zz27XWgzuwUJ0xHlKX4YUb2B6kmUkZR15eC","news_summary":"Can AI Lead to Pregnancy?","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b347f5ba-6908-4fdd-8629-f496b1531739","date":"Jun 5, 2020","link":"https://www.healtheuropa.eu/aivf-deploys-technology-and-innovation-to-boost-reproductive-science/100511/","source":"www.healtheuropa.eu","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"ETG7cFOAuL6ZFGzvq7ifd9CYc6TiUDDVv5eS3ZM6YdnyqUaLZSilac","news_summary":"AIVF deploys technology and innovation to boost reproductive science","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"55ea6f79-839d-4655-9504-5a1c6c6bf933","date":"Jul 31, 2019","link":"https://www.startuphub.ai/this-israeli-startup-is-using-deep-learning-and-computer-vision-to-revolutionize-ivf-treatments/","source":"www.startuphub.ai","visible":1,"analysis":{"tags":"AI, IVF, Healthcare","company":"AIVF","layoffs":"N/A","summary":"Israeli startup AIVF is developing an artificial intelligence (AI) based system to optimize the embryo selection process in In-Vitro Fertilization (IVF) treatments. The AI system is designed to increase success rates, reduce costs, and increase lab capacity. AIVF has partnered with Israeli private hospital Assuta and eight other clinics worldwide, and currently holds the largest dataset of over 250,000 time-lapse videos of developing embryos. The company plans to start clinical trials in 2020 and aims to receive regulatory approval for usage of the system in clinics in 2021.","partners":"Assuta","customers":"N/A","investors":"N/A","confidence":9,"key_topics":"Artificial Intelligence, In-Vitro Fertilization, Embryo Selection, Clinical Trials, Healthcare","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Partners, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zWJMGIwOTITzIlheWbdyffzJVrMGrCHMzLljGfEGvlDnfZDnBqwRIZ","news_summary":"This Israeli Startup is Using Deep Learning and Computer Vision to Revolutionize IVF Treatments","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4be21582-ecfc-4450-a1c9-ec4f2a4b5a60","date":"Apr 14, 2019","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3760370,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"startup competition","company":"Pitango Venture Capital","layoffs":null,"summary":"Pitango Venture Capital unveiled the 11 semi-finalists of its $1 million startup competition at Calcalists Mind the Tech Conference. The competition focuses on the intersection of data, machines, and humans. The semi-finals were held in New York, with the finals scheduled to take place in Israel in June. The startups showcased various technologies, including pool safety cameras, computer vision solutions, artificial intelligence for IVF embryo selection, and more. The competition aims to support and promote innovative startups in the tech industry.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["startups","technology","competition","venture capital","data"],"date_of_event":"14.04.19","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bkMySQ8l94blprq2NSaisQNOixKqX3WSXXsevqrb1cVnWR0478qPAO","news_summary":"Pitango's $1 Million Startup Competition Semi-Finalists Unveiled in New York","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":13,"techcommunityinvolvement":null,"mediagallery":[{"id":"jAxv3IHeG0QY9DcAsWZ3Ju4LmaRbEq0yUDXTIOtlcZ6OLHT3Y3RXIY","timestamp":"2023-10-12 12:45:59.000000","resources_type":2,"resources_title":"","resources_file_name":"4JwRyJPy1FQ","alt":"","imageurl":"https://img.youtube.com/vi/4JwRyJPy1FQ/0.jpg","url":"http://youtu.be/4JwRyJPy1FQ"},{"id":"75a9b3d2-a6d9-4b19-a98f-fa453dbbcc53","timestamp":"2019-02-28 06:17:02.000000","resources_type":2,"resources_title":"Meet Aivf 2 short version","resources_file_name":"fwYmriiR9EU","alt":"Meet Aivf 2 short version logo","imageurl":"https://img.youtube.com/vi/fwYmriiR9EU/0.jpg","url":"http://youtu.be/fwYmriiR9EU"},{"id":"44a9585a-db4a-4b3c-a812-1511e863f4b9","timestamp":"2019-02-28 06:16:49.000000","resources_type":2,"resources_title":"Meet Aivf 2","resources_file_name":"FBx9cBb7mYY","alt":"Meet Aivf 2 logo","imageurl":"https://img.youtube.com/vi/FBx9cBb7mYY/0.jpg","url":"http://youtu.be/FBx9cBb7mYY"}],"tags":["femtech","women-health","gynecology","machine-learning","data-analytics","fertility","artificial-intelligence","digital-healthcare","healthcare","mhealth","non-invasive","doctors","academia","hospitals","clinics","decision-support","genetics","deep-neural-networks","computer-vision"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-ivsJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["EMA"],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":3,"lastfunding":"$25M","totalrounds":1,"fundingstage":"A","totalfunding":"$25M","publicinvestors":3,"lastpublicfunding":25000000,"totalpublicrounds":1,"totalpublicfunding":25000000},"team":[{"name":"Daniella Gilboa","email":"daniella.gilboa@aivf.co","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPvR1IILDA","bounced":false,"claimed":0,"founder":1,"urlname":"daniella-gilboa-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgm77RwggM","position":"Co-founder & CEO","last_name":"Gilboa","claimtoken":"sH7zeAi2CXGj3m7j7gBRMJNVAqxE7CFxk1DZRmZp47RLbv3ejinsgN","first_name":"Daniella","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daniella-gilboa-20295713/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-10-12 12:48:58.000000","initials":"DG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Prof. Daniel Seidman","email":"daniel@aivf.co","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPuSi4UKDA","bounced":true,"claimed":0,"founder":1,"urlname":"prof-daniel-seidman","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg-5GY8QoM","position":"Co-founder & CMO","last_name":"Seidman","claimtoken":"2RNOaatrKzJItgQqAVvqMjeXludJfWHoEdbkWL7U2pgKnSOTQtfV51","first_name":"Prof. Daniel","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daniel-seidman-17b489a0/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-30 15:16:05.000000","initials":"PS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eyal  Veitzman","email":"eyal.veitzman@aivf.co","phone":"","gender":"Male","userid":"0GaL8UuS7lCvKsziIeG6o3KRUn23QIv8thrRTpwbKcheOlSBmyYuy4","bounced":true,"claimed":null,"founder":0,"urlname":"eyal-veitzman","visible":1,"memberid":"9wRvl71rjJJrgEsnSquW3g8LWHbgWjgrpvzrnr2Rhd3j5YrIw48h9c","position":"COO","last_name":"Veitzman","claimtoken":"Su78ZfbKDKnJyYTYJzidXvCXk5uGoVeEmQr45w8efXXLjIREpYEfF2","first_name":"Eyal ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/veitzman/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-10-12 12:51:53.000000","initials":"EV","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPW8rMQKDA","fullname":"Lena Rogovina"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2019-11-19T00:00:00.000Z","crunchbaseid":"aivf","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yonatan Dolan","creator_email":"yonatan.dolan@gmail.com","createdate":"2019-02-27T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":"Lena Rogovina","affiliatedOrganizations":null,"timeline":[{"id":"u6I1jpvNiaacsjtGSvk7qxoZL8hkNd62FtT1BD2S0yVXM4YlndM3RG","hub":"Google for Startups Accelerator","date":"Jan 2023","batch":"1","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPO05JYLDA","source":"https://www.calcalistech.com/ctechnews/article/pgg54w4uw","enddate":"Apr 2023","hub_type":"Corporate Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/google-for-startups-accelerator","hub_logokey":"$VXwMfIEVbzhfJ3s6S0EUT6jzYU3aTzNuNLGlj63o2NAXWpzj6RjB9k","hub_urlname":"/program_page/google-for-startups-accelerator","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$VXwMfIEVbzhfJ3s6S0EUT6jzYU3aTzNuNLGlj63o2NAXWpzj6RjB9k","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"DPDsHXFirSYT5jqFqfmd3w4ONIffRNTT39mw5DhXYtoVoYtToYS2JI","date":"Oct 2022","amount":"Undisclosed","source":"https://www.prnewswire.com/il/news-releases/aivf-acquires-art-compass-to-drive-the-digital-transformation-of-fertility-care-301657285.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Art Compass","acquiredcompany_mna_id":"LGnyIIoiP1WwNkLHL1Rip9c8lwQ236TL0euswT0ippX87xEHbtXWDj","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/art-compass","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/company_page/art-compass","acquiredcompany_mna_homepage":null,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJD8pp6VCQw","date":"Jun 2022","amount":"$25M","source":"https://www.businesswire.com/news/home/20220622005156/en/AiVF-Raises-25-Million-in-Series-A-Round-Led-by-Insight-Partners-to-Help-More-People-Become-Parents","eventtype":"FundingRoundEvent","investment":[{"name":"Insight Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/insight-partners","logokey":"$DL56QgFEG8e9HuXHA5roycH0sJYhu3JyCjjxBIkWhPHZ1dpRRHPbIx","tagline":null,"urlname":"/investor_page/insight-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Kr0yfULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"58878143-d116-464d-b94b-939102dd6cd1","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$DL56QgFEG8e9HuXHA5roycH0sJYhu3JyCjjxBIkWhPHZ1dpRRHPbIx","leadcaption":"Lead ","followupcaption":""},{"name":"Adam Neumann","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/adam-neumann","logokey":"$1BXfYamIDLCf6iAFqllthUlTvhRpfxlRn9km9qVCcjItKOF4690Z1L","tagline":null,"urlname":"/investor_page/adam-neumann","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkKLRrq0KDA","fundingtype":"Angel","leadpartner":null,"investmentid":"992b23b3-fed4-4517-bac9-46f9e226735c","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1BXfYamIDLCf6iAFqllthUlTvhRpfxlRn9km9qVCcjItKOF4690Z1L","leadcaption":"","followupcaption":""},{"name":"Alora Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/alora-ventures","logokey":"$yCiQxuVJ97KD662vUpouh9kGG4Cn3i83A6RMRx7lQf4KMITRpebFIO.png","tagline":null,"urlname":"/investor_page/alora-ventures","isisraeli":0,"investorid":"TqdtTpa5sWm1MCmMoubjLbNxdd5BGVD5uMPRCrYaNarhWb0s9wkXu2","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HJyUCkvvIy53RA6fuau6gtXqw6T85qtZbeclbIOQlbtOhqDiRbjJP8","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yCiQxuVJ97KD662vUpouh9kGG4Cn3i83A6RMRx7lQf4KMITRpebFIO.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"AIVF","logourl":"https://storage.googleapis.com/clean-finder-353810/$vewjWY0QJJU5D1rnVIcDyP9g25kakM2sxh7jc0jK0d1Kgx11XchPLa.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$vewjWY0QJJU5D1rnVIcDyP9g25kakM2sxh7jc0jK0d1Kgx11XchPLa.jpeg","seoabout":"AIVF is leading the next generation of IVF. The company is on a mission to help patients, clinics and labs achieve the best IVF outcomes by developing adva...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Computer Vision","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEKDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Education","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Higher Education","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-ivsJDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Computer Vision#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA","IndustryClassificationModel>Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA>Higher Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-ivsJDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|1:>IndustryClassificationModel/Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA|2:>IndustryClassificationModel>Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA/Higher Education#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-ivsJDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Computer Vision#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEKDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Medical Decision Support","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]}]}],"targetCustomer":[{"title":"Consumers","key":"0-0","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Women","key":"0-0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Women"}]}]},{"title":"Healthcare & Life Sciences","key":"0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-1-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]},{"title":"Education","key":"0-2","path":"IndustryClassificationModel>Education","children":[{"title":"Higher Education","key":"0-2-0","path":"IndustryClassificationModel>Education>Higher Education"}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Computer Vision","key":"0-0-0","path":"TechnologyClassificationModel>Artificial Intelligence>Computer Vision"},{"title":"Machine Learning","key":"0-0-1","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]},{"title":"Biologicals","key":"0-1","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Genes","key":"0-1-0","path":"TechnologyClassificationModel>Biologicals>Genes"}]},{"title":"Platforms & Interfaces","key":"0-2","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Software","key":"0-2-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Computer Vision","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEKDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Education","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT5_EIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Higher Education","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-ivsJDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Medical Decision Support"],"coreTechnology":["Artificial Intelligence","Computer Vision","Machine Learning","Biologicals","Genes","Platforms & Interfaces","Software"],"targetCustomer":["Consumers","Demographics & Family","Women","Healthcare & Life Sciences","Healthcare","Providers","Education","Higher Education"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJD8pp6VCQw","date":"Jun 2022","amount":"$25M","source":"https://www.businesswire.com/news/home/20220622005156/en/AiVF-Raises-25-Million-in-Series-A-Round-Led-by-Insight-Partners-to-Help-More-People-Become-Parents","eventtype":"FundingRoundEvent","investment":[{"name":"Insight Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/insight-partners","logokey":"$DL56QgFEG8e9HuXHA5roycH0sJYhu3JyCjjxBIkWhPHZ1dpRRHPbIx","tagline":null,"urlname":"/investor_page/insight-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Kr0yfULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"58878143-d116-464d-b94b-939102dd6cd1","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$DL56QgFEG8e9HuXHA5roycH0sJYhu3JyCjjxBIkWhPHZ1dpRRHPbIx","leadcaption":"Lead ","followupcaption":""},{"name":"Adam Neumann","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/adam-neumann","logokey":"$1BXfYamIDLCf6iAFqllthUlTvhRpfxlRn9km9qVCcjItKOF4690Z1L","tagline":null,"urlname":"/investor_page/adam-neumann","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkKLRrq0KDA","fundingtype":"Angel","leadpartner":null,"investmentid":"992b23b3-fed4-4517-bac9-46f9e226735c","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1BXfYamIDLCf6iAFqllthUlTvhRpfxlRn9km9qVCcjItKOF4690Z1L","leadcaption":"","followupcaption":""},{"name":"Alora Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/alora-ventures","logokey":"$yCiQxuVJ97KD662vUpouh9kGG4Cn3i83A6RMRx7lQf4KMITRpebFIO.png","tagline":null,"urlname":"/investor_page/alora-ventures","isisraeli":0,"investorid":"TqdtTpa5sWm1MCmMoubjLbNxdd5BGVD5uMPRCrYaNarhWb0s9wkXu2","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HJyUCkvvIy53RA6fuau6gtXqw6T85qtZbeclbIOQlbtOhqDiRbjJP8","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yCiQxuVJ97KD662vUpouh9kGG4Cn3i83A6RMRx7lQf4KMITRpebFIO.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[{"id":"DPDsHXFirSYT5jqFqfmd3w4ONIffRNTT39mw5DhXYtoVoYtToYS2JI","date":"Oct 2022","amount":"Undisclosed","source":"https://www.prnewswire.com/il/news-releases/aivf-acquires-art-compass-to-drive-the-digital-transformation-of-fertility-care-301657285.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Art Compass","acquiredcompany_mna_id":"LGnyIIoiP1WwNkLHL1Rip9c8lwQ236TL0euswT0ippX87xEHbtXWDj","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/art-compass","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/company_page/art-compass","acquiredcompany_mna_homepage":null,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"others":[]}}